The study of effects of combination of puerarin and compound salvia miltiorrhiza on thrombogenic and fibrinolytic activities in patients with unstable angina pectoris

LIU Miao,ZHANG Qi-zhi
DOI: https://doi.org/10.3969/j.issn.1672-5301.2007.07.019
2007-01-01
Abstract:Objective To study the curative effects and influence of fibrinolytic and thrombogenic activities after puerarin and compound salvia miltiorrhiza therapy on patients with unstable angina pectoris.Methods 100 cases of unstable angina pectoris patients were randomly choose and randomly divided into two groups,which include treatment group(50 cases) and control group(50 cases) on the basis of traditional therapy.The patients in treatment group were administrated puerarin and compound salvia miltiorrhiza for 14 days and those in control group were only administrated compound salvia miltiorrhiza for 14 days.The parameters of fibrinolytic or thrombogenic activities and therapy effects of angina pectoris,ECG of patients in two groups were observed.Results In both groups,the serum levels of von willebrand factor(VWF),plasminogen activator inhibitor-1(PAI-1)and fibrinogen were lower than those before treatment(P<0.05),and the serum levels of tissue plasminogen activator(t-PA)and antithrombin Ⅲ(AT-Ⅲ) were higher than those before treatment(P<0.05).Compared with the control group,the changes in treatment group were significant(P<0.05).The therapy effects of angina pectoris and ECG of patients in treatment group were higher than those of the control group(P<0.05).There was no significant difference between the side effects of two groups(P<0.05).Conclusion Compared with compound salvia miltiorrhiza,combination of puerarin and compound salvia miltiorrhiza can effectively improve fibrinolytic and thrombogenic activities in patients with unstable angina pectoris,and presented good clinical therapy effects.It is an ideal regimen for treatment of unstable angina pectoris.
What problem does this paper attempt to address?